Literature DB >> 28861912

Diagnosis checking of statistical analysis in RCTs indexed in PubMed.

Paul H Lee1, Andy C Y Tse2.   

Abstract

BACKGROUND: Statistical analysis is essential for reporting of the results of randomized controlled trials (RCTs), as well as evaluating their effectiveness. However, the validity of a statistical analysis also depends on whether the assumptions of that analysis are valid.
OBJECTIVE: To review all RCTs published in journals indexed in PubMed during December 2014 to provide a complete picture of how RCTs handle assumptions of statistical analysis.
METHODS: We reviewed all RCTs published in December 2014 that appeared in journals indexed in PubMed using the Cochrane highly sensitive search strategy. The 2014 impact factors of the journals were used as proxies for their quality. The type of statistical analysis used and whether the assumptions of the analysis were tested were reviewed.
RESULTS: In total, 451 papers were included. Of the 278 papers that reported a crude analysis for the primary outcomes, 31 (27·2%) reported whether the outcome was normally distributed. Of the 172 papers that reported an adjusted analysis for the primary outcomes, diagnosis checking was rarely conducted, with only 20%, 8·6% and 7% checked for generalized linear model, Cox proportional hazard model and multilevel model, respectively. Study characteristics (study type, drug trial, funding sources, journal type and endorsement of CONSORT guidelines) were not associated with the reporting of diagnosis checking.
CONCLUSION: The diagnosis of statistical analyses in RCTs published in PubMed-indexed journals was usually absent. Journals should provide guidelines about the reporting of a diagnosis of assumptions.
© 2017 Stichting European Society for Clinical Investigation Journal Foundation.

Entities:  

Keywords:  Assumption; diagnosis; protocol; statistics; trials

Mesh:

Year:  2017        PMID: 28861912     DOI: 10.1111/eci.12833

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  2 in total

1.  Nonspecific intraventricular conduction delay is associated with future occurrence of atrial fibrillation in patients with structurally normal heart.

Authors:  Jae-Sun Uhm; Youngchae Lee; Yun Ho Roh; Jinae Lee; Dongseon Kang; Moo-Nyun Jin; In-Soo Kim; Hee Tae Yu; Tae-Hoon Kim; Jong-Youn Kim; Boyoung Joung; Hui-Nam Pak; Moon-Hyoung Lee
Journal:  Eur J Intern Med       Date:  2019-11-14       Impact factor: 4.487

2.  The quality of the reported sample size calculation in clinical trials on COVID-19 patients indexed in PubMed.

Authors:  Paul H Lee
Journal:  Eur J Intern Med       Date:  2020-04-30       Impact factor: 4.487

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.